Narjust Florez
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Narjust Florez
Dec 30, 2023, 17:33 |
Opinion
Narjust Florez: Let me share a few things I learned this year
Narjust Florez shared on X: "Let me share a few things I learned this year:…
Dec 27, 2023, 13:26 |
Blog
Narjust Florez: Check out our conference website!
Narjust Florez shared on X: "Check out our conference website! 2024 World Conference of Lung…
Dec 26, 2023, 13:21 |
Insight
Yvonne Diaz: SHAWL study finds providers have not yet registered this new reality for approximately 80% of us
Yvonne Diaz, Co-founder of Oncogene Cancer, posted X/Twitter: "More younger women are getting lung cancer. In patients…
Dec 7, 2023, 23:10 |
Blog
Yvonne Diaz: Was great to join in an ALK+ lung cancer focused episode of IASLC Lung Cancer Considered
Yvonne Diaz, Co-Founder of Oncogene Cancer Research, made the following post on Twitter: "Was great…
Dec 5, 2023, 19:09 |
Blog
Narjust Florez: Ready for a Pregnancy and Lung Cancer Tweetorial?
Narjust Florez shared a post on her X/Twitter page: "Ready for a Pregnancy and Lung…
Dec 2, 2023, 15:31 |
Blog
Narjust Florez: The first pregnancy and lung cancer registry!
Narjust Florez shared a post on her X/Twitter page: "Launching today! The first pregnancy and…
Nov 14, 2023, 18:53 |
Blog
Narjust Florez: Stephen V Liu discusses a REALISTIC approach to working with our patients and their families while waiting for biomarker testing
Narjust Florez, shared a post on X/Twitter: "Dr. Stephen V Liu discusses a REALISTIC approach…
Nov 6, 2023, 17:54 |
Insight
Narjust Florez: It’s time to pay attention to lung cancer in women!
Narjust Florez shared on Twitter: "Lung cancer claims the lives of more women in the U.S.…
Nov 4, 2023, 00:39 |
Opinion
Narjust Florez: Discharge is the time when patients are most vulnerable
Narjust Florez shared in Twitter: "Discharge is the time when patients are most vulnerable. A…
Oct 17, 2023, 01:30 |
Stories
Narjust Florez: Vulnerability is powerful and storytelling is healing
Narjust Florez shared on Twitter: "Vulnerability is powerful and storytelling is healing. Honored to be…
Oct 9, 2023, 18:54 |
Blog
Ishwaria Subbiah: And that’s a wrap! Cheers from your planning committee for the 2023 Workshop on Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care, co-hosted by ASCO and National Cancer Policy Forum!
Oct 1, 2023, 19:47 |
Insight
In this American Society of Clinical Oncology Connection Guest Commentary, Narjust Florez, Fatima Wilder Lauren Kiel, Rebekah Kaufman provide expert recommendations for Young Adults with Lung Cancer. - Florez Lab
Oct 1, 2023, 16:31 |
Blog
Narjust Florez: Join us at the 5th Annual Precision Medicine Symposium: An Illustrated Tumor Board Registration.
Narjust Florez shared on X/Twitter: "Not going to the European Society for Medical Oncology? Don't…
Sep 28, 2023, 18:36 |
Insight
Maite Bourlon: Happy collaborator: Women, Power and Cancer at The Lancet Commission.
Quoting Maite Bourlon, Fellow at JCO Global Oncology, on X/Twitter: "Happy collaborator: Women, Power and…
Sep 20, 2023, 18:28 |
Blog
Princess Dina Mired: So happy to have listened to these amazing women Fiona Hegi- Johnson and Heather Wakelee.
Princess Dina Mired replied to a post by IASLC on X/Twitter: “Thank you Narjust Florez…
Sep 14, 2023, 18:08 |
Blog
,
Stories
Top 9 posts you dont wanna wiss from WCLC
The 2023 World Conference on Lung Cancer took place in Singapore from September 9-12. Our…
Sep 14, 2023, 15:53 |
Blog
Estela Rodriguez: Very special Women Who Conquer Cancer Event raising money for the next Conquer Cancer, the ASCO Foundation Latina YIA Grant.
Estela Rodriguez made the following post on X/Twitter: "Physicians make up only 4.7% of the…
Sep 12, 2023, 19:49 |
Blog
Narjust Florez: Little Narjust would have never imaged I will have the honor to interview HRH Princess Dina Mired of Jordan one day.
Quoting Narjust Florez on X/Twitter: ''Little Narjust would have never imaged I will have the…
Sep 11, 2023, 18:00 |
Blog
Narjust Florez: Promoting Health Equity in Science Communication - My Tips.
Quoting Narjust Florez on X/Twitter: ''Promoting Health Equity in Science Communication - My tips 1.…
Sep 11, 2023, 17:32 |
Blog
Neal Augenstein: As a journalist and lung cancer patient, here’s an example of the power of podcast.
Quoting Neal Augenstein on X/Twitter: ''As a journalist and lung cancer patient, here’s an example of…
Sep 5, 2023, 17:44 |
Blog
Narjust Florez: Applying for fellowship? From fellowship application to surviving the first year!
Narjust Florez recently tweeted: "Applying for fellowship? Check out this new episode of Lung Cancer…
Sep 2, 2023, 19:28 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 2
Last week, on August 26, which is Women’s Equality Day in the United States, OncoDaily…
Aug 27, 2023, 18:29 |
Blog
Narjust Florez: Join us as we discuss the role of cultural humility in cancer survivorship in this conversation with my mentor Dr. Ann Partridge.
Narjust Florez, the Associate Director of the Cancer Care Equity Program at the Dana-Farber Brigham…
Aug 26, 2023, 22:39 |
Blog
Narjust Florez: Stay tuned! For an upcoming episode of Lung Cancer Considered w/ Drs. Christine Garcia, Regina Barragan-Carrillo and Jennifer Marks on oncology training.
Narjust Florez, Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist…
Aug 18, 2023, 18:24 |
Blog
Narjust Florez: More and more young women are coming to my clinic.
Quoting Narjust Florez, Associate Director of the Cancer Care Equity Program and a thoracic medical…
Aug 16, 2023, 19:35 |
Societies
Increasingly, oncologists and lung cancer researchers are including Artificial Intele as part of their research/patient care; - IASLC
According to IASLC on Twitter: "Increasingly, oncologists & lung cancer researchers are including AI as…
1
2
All:
126
Posts:
101 - 200
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube